These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12515289)

  • 21. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.
    Raju R; Foote J; Banga JP; Hall TR; Padoa CJ; Dalakas MC; Ortqvist E; Hampe CS
    J Immunol; 2005 Dec; 175(11):7755-62. PubMed ID: 16301686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients.
    Hou J; Said C; Franchi D; Dockstader P; Chatterjee NK
    Diabetes; 1994 Oct; 43(10):1260-6. PubMed ID: 7523207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
    Richter W; Shi Y; Baekkeskov S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
    Daw K; Powers AC
    Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes.
    Lühder F; Schlosser M; Mauch L; Haubruck H; Rjasanowski I; Michaelis D; Kohnert KD; Ziegler M
    Autoimmunity; 1994; 19(2):71-80. PubMed ID: 7772705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
    Reijonen H; Daniels TL; Lernmark A; Nepom GT
    Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies.
    Marcovina SM; Landin-Olsson M; Essen-Möller A; Palmer JP; Lernmark A
    Int J Clin Lab Res; 2000; 30(1):21-6. PubMed ID: 10984128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of autoantibody epitopes on steroid 21-hydroxylase using a panel of monoclonal antibodies.
    Chen S; Sawicka J; Prentice L; Sanders JF; Tanaka H; Petersen V; Betterle C; Volpato M; Roberts S; Powell M; Smith BR; Furmaniak J
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2977-86. PubMed ID: 9709979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of glutamic acid decarboxylase (GAD) autoantibodies by indirect immunofluorescence using CHO cells expressing recombinant human GAD65.
    Papouchado ML; Ermácora MR; Poskus E
    J Autoimmun; 1996 Oct; 9(5):689-97. PubMed ID: 8933286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast.
    Powell M; Prentice L; Asawa T; Kato R; Sawicka J; Tanaka H; Petersen V; Munkley A; Morgan S; Rees Smith B; Furmaniak J
    Clin Chim Acta; 1996 Dec; 256(2):175-88. PubMed ID: 9027428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the GAD65-GAD65 autoantibody interaction.
    Coco G; Chen S; Powell M; Brooking H; Zanchetta R; Betterle C; Smith BR; Furmaniak J
    Clin Chim Acta; 2008 May; 391(1-2):51-9. PubMed ID: 18328264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
    Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered variants of human glutamic acid decarboxylase (GAD) and autoantibody epitope recognition.
    Primo ME; Anton EA; Villanueva AL; Poskus E; Ermácora MR
    Clin Immunol; 2003 Jul; 108(1):38-45. PubMed ID: 12865069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
    Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
    Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11.
    Fenalti G; Hampe CS; O'connor K; Banga JP; Mackay IR; Rowley MJ; El-Kabbani O
    Mol Immunol; 2007 Feb; 44(6):1178-89. PubMed ID: 16930708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and/or type 1 diabetes.
    Ronkainen MS; Härkönen T; Perheentupa J; Knip M
    Eur J Endocrinol; 2005 Dec; 153(6):901-6. PubMed ID: 16322397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
    Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
    Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.
    Park H; Yu L; Kim T; Cho B; Kang J; Park Y
    Ann N Y Acad Sci; 2006 Oct; 1079():213-9. PubMed ID: 17130557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for somatic mutation and affinity maturation of diabetes associated human autoantibodies to glutamate decarboxylase.
    Jury KM; Loeffler D; Eiermann TH; Ziegler B; Boehm BO; Richter W
    J Autoimmun; 1996 Jun; 9(3):371-7. PubMed ID: 8816973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II.
    Seissler J; Bieg S; Yassin N; Mauch L; Northemann W; Boehm BO; Scherbaum WA
    Autoimmunity; 1994; 19(4):231-8. PubMed ID: 7578849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.